FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3009593604> ?p ?o ?g. }

• W3009593604 endingPage "e0229581" @default.
• W3009593604 startingPage "e0229581" @default.
• W3009593604 abstract "Multidrug-resistant non-typhoidal Salmonella (NTS) infection has emerged as a prominent cause of invasive infections in Africa. We investigated the prevalence of ceftriaxone-resistant invasive NTS infections, conducted exploratory analysis of risk factors for resistance, and described antimicrobial use in western Kenya. We conducted a secondary analysis of existing laboratory, epidemiology, and clinical data from three independent projects, a malaria vaccine trial, a central nervous system (CNS) study, and the International Emerging Infections Program morbidity surveillance (surveillance program) during 2009-2014. We calculated odds ratios (OR) with 95% confidence intervals (CI) for ceftriaxone-resistant NTS infections compared with ceftriaxone-susceptible infections. We surveyed hospitals, pharmacies, and animal drug retailers about the availability and use of antimicrobials. In total, 286 invasive NTS infections were identified in the three projects; 43 NTS isolates were ceftriaxone-resistant. The absolute prevalence of ceftriaxone resistance varied among these methodologically diverse projects, with 18% (16/90) of isolates resistant to ceftriaxone in the vaccine trial, 89% (16/18) in the CNS study, and 6% (11/178) in the surveillance program. Invasive ceftriaxone-resistant infections increased over time. Most ceftriaxone-resistant isolates were co-resistant to multiple other antimicrobials. Having an HIV-positive mother (OR = 3.7; CI = 1.2-11.4) and taking trimethoprim-sulfamethoxazole for the current illness (OR = 9.6, CI = 1.2-78.9) were significantly associated with acquiring ceftriaxone-resistant invasive NTS infection. Ceftriaxone and other antibiotics were widely prescribed; multiple issues related to prescription practices and misuse were identified. In summary, ceftriaxone-resistant invasive NTS infection is increasing and limiting treatment options for serious infections. Efforts are ongoing to address the urgent need for improved microbiologic diagnostic capacity and an antimicrobial surveillance system in Kenya." @default.
• W3009593604 created "2020-03-13" @default.
• W3009593604 creator A5010100797 @default.
• W3009593604 creator A5012894836 @default.
• W3009593604 creator A5020161648 @default.
• W3009593604 creator A5022930706 @default.
• W3009593604 creator A5033225991 @default.
• W3009593604 creator A5037723243 @default.
• W3009593604 creator A5046188982 @default.
• W3009593604 creator A5060215330 @default.
• W3009593604 creator A5073201259 @default.
• W3009593604 creator A5075423151 @default.
• W3009593604 creator A5076363055 @default.
• W3009593604 creator A5084910857 @default.
• W3009593604 creator A5086245832 @default.
• W3009593604 date "2020-03-03" @default.
• W3009593604 modified "2023-10-14" @default.
• W3009593604 title "Exploration of risk factors for ceftriaxone resistance in invasive non-typhoidal Salmonella infections in western Kenya" @default.
• W3009593604 cites W1565864573 @default.
• W3009593604 cites W1745685572 @default.
• W3009593604 cites W1979075972 @default.
• W3009593604 cites W1991860284 @default.
• W3009593604 cites W2063176128 @default.
• W3009593604 cites W2090839261 @default.
• W3009593604 cites W2118259956 @default.
• W3009593604 cites W2119918936 @default.
• W3009593604 cites W2140353364 @default.
• W3009593604 cites W2140733996 @default.
• W3009593604 cites W2158084007 @default.
• W3009593604 cites W2170648792 @default.
• W3009593604 cites W2203291658 @default.
• W3009593604 cites W2470147986 @default.
• W3009593604 cites W2539082379 @default.
• W3009593604 cites W2543569802 @default.
• W3009593604 cites W2567899704 @default.
• W3009593604 cites W2587454028 @default.
• W3009593604 cites W2680254013 @default.
• W3009593604 cites W2792200975 @default.
• W3009593604 cites W2798042179 @default.
• W3009593604 cites W2889702281 @default.
• W3009593604 cites W2944761483 @default.
• W3009593604 doi "https://doi.org/10.1371/journal.pone.0229581" @default.
• W3009593604 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7053705" @default.
• W3009593604 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32126103" @default.
• W3009593604 hasPublicationYear "2020" @default.
• W3009593604 type Work @default.
• W3009593604 sameAs 3009593604 @default.
• W3009593604 citedByCount "3" @default.
• W3009593604 countsByYear W30095936042021 @default.
• W3009593604 countsByYear W30095936042023 @default.
• W3009593604 crossrefType "journal-article" @default.
• W3009593604 hasAuthorship W3009593604A5010100797 @default.
• W3009593604 hasAuthorship W3009593604A5012894836 @default.
• W3009593604 hasAuthorship W3009593604A5020161648 @default.
• W3009593604 hasAuthorship W3009593604A5022930706 @default.
• W3009593604 hasAuthorship W3009593604A5033225991 @default.
• W3009593604 hasAuthorship W3009593604A5037723243 @default.
• W3009593604 hasAuthorship W3009593604A5046188982 @default.
• W3009593604 hasAuthorship W3009593604A5060215330 @default.
• W3009593604 hasAuthorship W3009593604A5073201259 @default.
• W3009593604 hasAuthorship W3009593604A5075423151 @default.
• W3009593604 hasAuthorship W3009593604A5076363055 @default.
• W3009593604 hasAuthorship W3009593604A5084910857 @default.
• W3009593604 hasAuthorship W3009593604A5086245832 @default.
• W3009593604 hasBestOaLocation W30095936041 @default.
• W3009593604 hasConcept C126322002 @default.
• W3009593604 hasConcept C2776520383 @default.
• W3009593604 hasConcept C2780728791 @default.
• W3009593604 hasConcept C501593827 @default.
• W3009593604 hasConcept C71924100 @default.
• W3009593604 hasConcept C86803240 @default.
• W3009593604 hasConcept C89423630 @default.
• W3009593604 hasConcept C94665300 @default.
• W3009593604 hasConceptScore W3009593604C126322002 @default.
• W3009593604 hasConceptScore W3009593604C2776520383 @default.
• W3009593604 hasConceptScore W3009593604C2780728791 @default.
• W3009593604 hasConceptScore W3009593604C501593827 @default.
• W3009593604 hasConceptScore W3009593604C71924100 @default.
• W3009593604 hasConceptScore W3009593604C86803240 @default.
• W3009593604 hasConceptScore W3009593604C89423630 @default.
• W3009593604 hasConceptScore W3009593604C94665300 @default.
• W3009593604 hasIssue "3" @default.
• W3009593604 hasLocation W30095936041 @default.
• W3009593604 hasLocation W30095936042 @default.
• W3009593604 hasLocation W30095936043 @default.
• W3009593604 hasLocation W30095936044 @default.
• W3009593604 hasOpenAccess W3009593604 @default.
• W3009593604 hasPrimaryLocation W30095936041 @default.
• W3009593604 hasRelatedWork W2209191115 @default.
• W3009593604 hasRelatedWork W2461645720 @default.
• W3009593604 hasRelatedWork W2593063328 @default.
• W3009593604 hasRelatedWork W2611893654 @default.
• W3009593604 hasRelatedWork W2788631189 @default.
• W3009593604 hasRelatedWork W3013874502 @default.
• W3009593604 hasRelatedWork W3096793439 @default.
• W3009593604 hasRelatedWork W3211243023 @default.
• W3009593604 hasRelatedWork W4232182398 @default.
• W3009593604 hasRelatedWork W643799939 @default.

• next